Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada

References

• Bruneau J, Ahamad K, Goyer M-È, Poulin G, Selby P, Fischer B, Wild TC, Wood E, CIHR Canadian Research Initiative in Substance Misuse. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247–E257. doi:10.1503/CMAJ.170958.
   PubMed Web of Science ®Google Scholar
• Caplehorn JRM, Dalton MYNS, Haldar F, Petrenas A-M, Nisbet JG. Methadone Maintenance and addicts’ risk of fatal heroin overdose. Subst Use Misuse. 1996;31(2):177–96. doi:10.3109/10826089609045806.
   PubMed Web of Science ®Google Scholar
• Uhlmann S, Milloy M-J, Kerr T, Zhang R, Guillemi S, Marsh D, Hogg RS, Montaner JSG, Wood E. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13. doi:10.1111/j.1360-0443.2010.02905.x.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies-tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–6. doi:10.1056/NEJMp1402780.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Gryczynski J, O’Grady KE, Sharfstein JM, Warren G, Olsen Y, Mitchell SG, Jaffe JH. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health. 2013;103(5):917–22. doi:10.2105/AJPH.2012.301049.
   PubMed Web of Science ®Google Scholar
• Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL. Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection. Drug Alcohol Depend. 2003;69(3):263–72. doi:10.1016/S0376-8716(02)00325-3.
   PubMed Web of Science ®Google Scholar
• Donroe JH, Holt SR, Tetrault JM. Caring for patients with opioid use disorder in the hospital. CMAJ. 2016;188(17-18):1232–9. doi:10.1503/cmaj.160290.
   PubMed Web of Science ®Google Scholar
• Noska A, Mohan A, Wakeman S, Rich J, Boutwell A. Managing opioid use disorder during and after acute hospitalization: a case-based review clarifying methadone regulation for acute care settings. J Addict Behav Ther Rehabil. 2015;4(2) doi:10.4172/2324-9005.1000138.
   PubMedGoogle Scholar
• Dematteis M, Auriacombe M, D’Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, et al. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opin Pharmacother. 2017;18(18):1987–99. doi:10.1080/14656566.2017.1409722.
   PubMed Web of Science ®Google Scholar
• British Columbia Centre on Substance Use; B.C. Ministry of Health. A Guideline for the Clinical Management of Opioid Use Disorder.; 2017. Accessed November 11, 2018. http://www.bccsu.ca/wp-content/uploads/2017/06/BC-OUD-Guidelines_June2017.pdf.
   Google Scholar
• Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S, Stein M. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369–76. doi:10.1001/jamainternmed.2014.2556.
   PubMed Web of Science ®Google Scholar
• Morozova O, Dvoryak S, Altice FL. Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine. Int J Drug Policy. 2013;24(6):e91–e98. doi:10.1016/j.drugpo.2013.09.001.
   PubMedGoogle Scholar
• Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: a case series. Am J Addict. 2015;24(1):10–4. doi:10.1111/ajad.12161.
   PubMed Web of Science ®Google Scholar
• Caldiero RM, Parran TV, Adelman CL, Piche B. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved? Am J Addict. 2006;15(1):1–7. doi:10.1080/10550490500418989.
   PubMed Web of Science ®Google Scholar
• Cushman PA, Liebschutz JM, Anderson BJ, Moreau MR, Stein MD. Buprenorphine initiation and linkage to outpatient buprenorphine do not reduce frequency of injection opiate use following hospitalization. J Subst Abuse Treat. 2016;68:68–73. doi:10.1016/j.jsat.2016.06.003.
   PubMed Web of Science ®Google Scholar
• Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5):358–67. doi:10.1097/ADM.0000000000000166.
   PubMed Web of Science ®Google Scholar
• Oliva EM, Maisel NC, Gordon AJ, Harris AHS. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13(5):374–81. doi:10.1007/s11920-011-0222-2.
   PubMed Web of Science ®Google Scholar
• Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2-3):188–96. doi:10.1016/J.DRUGALCDEP.2006.10.014.
   PubMed Web of Science ®Google Scholar
• Woo J, Bhalerao A, Bawor M, Bhatt M, Dennis B, Mouravska N, Zielinski L, Samaan Z. “Don’t judge a book its cover”: a qualitative study of methadone patients’ experiences of stigma. Subst Abuse. 2017;11:1178221816685087 doi:10.1177/1178221816685087.
   Web of Science ®Google Scholar
• Earnshaw V, Smith L, Copenhaver M. Drug addiction stigma in the context of methadone maintenance therapy: an investigation into understudied sources of stigma. Int J Ment Health Addict. 2013;11(1):110–22. doi:10.1007/s11469-012-9402-5.
   PubMed Web of Science ®Google Scholar
• Ti L, Voon P, Dobrer S, Montaner J, Wood E, Kerr T. Denial of pain medication by health care providers predicts in-hospital illicit drug use among individuals who use illicit drugs. Pain Res Manag. 2015;20(2):84–8. doi:10.1155/2015/868746.
   PubMed Web of Science ®Google Scholar
• McNeil R, Small W, Wood E, Kerr T. Hospitals as a “‘risk environment’: an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs”. Soc Sci Med. 2014;105:59–66. doi:10.1016/j.socscimed.2014.01.010.
   PubMed Web of Science ®Google Scholar
• Trafton JA, Minkel J, Humphreys K. Determining effective methadone doses for individual opioid-dependent patients. PLoS Med. 2006;3(3):e80. doi:10.1371/journal.pmed.0030080.
   PubMed Web of Science ®Google Scholar
• Farrell M. Opiate withdrawal. Addiction. 1994;89(11):1471–5. doi:10.1111/j.1360-0443.1994.tb03745.x.
   PubMed Web of Science ®Google Scholar
• Wood E, Stoltz J-A, Montaner JS, Kerr T. Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study. Harm Reduct J. 2006;3(1):18 doi:10.1186/1477-7517-3-18.
   PubMedGoogle Scholar
• Wood E, Kerr T, Marshall BDL, Li K, Zhang R, Hogg RS, Harrigan PR, Montaner JSG. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338(apr30 1):b1649. doi:10.1136/bmj.b1649.
   PubMedGoogle Scholar
• Strathdee SA, Palepu A, Cornelisse PG, Yip B, O’Shaughnessy MV, Montaner JS, Schechter MT, Hogg RS. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547–9. doi:10.1001/jama.280.6.547.
   PubMed Web of Science ®Google Scholar
• Kennedy MC, McNeil R, Milloy MJ, Dong H, Kerr T, Hayashi K. Residential eviction and exposure to violence among people who inject drugs in Vancouver, Canada. Int J Drug Policy. 2017;41:59–64. doi:10.1016/j.drugpo.2016.12.017.
   PubMed Web of Science ®Google Scholar
• Neale J. Homelessness amongst drug users: a double jeopardy explored. Int J Drug Policy. 2001;12(4):353–69. doi:10.1016/S0955-3959(01)00097-4.
   Google Scholar
• Johnson TP, Fendrich M. Homelessness and drug use: evidence from a community sample. Am J Prev Med. 2007;32(6 Suppl):S211–S218. doi:10.1016/j.amepre.2007.02.015.
   PubMed Web of Science ®Google Scholar
• Stevens CW, Yaksh TL. Studies of morphine and D-ala2-D-leu5-enkephalin (DADLE) cross-tolerance after continuous intrathecal infusion in the rat. Anesthesiology. 1992;76(4):596–603. Accessed May 28, 2019. http://www.ncbi.nlm.nih.gov/pubmed/1550284 doi:10.1097/00000542-199204000-00017.
   PubMed Web of Science ®Google Scholar
• Stevens CW, Yaksh TL. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord. J Pharmacol Exp Ther. 1989;251(1):216–23. Accessed May 28, 2019. [2795458]
   PubMed Web of Science ®Google Scholar
• Breakey WR, Fischer PJ, Kramer M, et al. Health and mental health problems of homeless men and women in Baltimore. JAMA. 1989;262(10):1352. doi:10.1001/jama.1989.03430100086034.
   PubMed Web of Science ®Google Scholar
• Fischer PJ, Breakey WR. The epidemiology of alcohol, drug, and mental disorders among homeless persons. Am Psychol. 1991;46(11):1115–28. doi:10.1037/0003-066X.46.11.1115
   PubMed Web of Science ®Google Scholar
• Koegel P, Burnam MA, Farr RK. The prevalence of specific psychiatric disorders among homeless individuals in the inner city of Los Angeles. Arch Gen Psychiatry. 1988;45(12):1085–92. doi:10.1001/archpsyc.1988.01800360033005.
   PubMed Web of Science ®Google Scholar
• Zlotnick C, Tam T, Robertson MJ. Disaffiliation, substance use, and exiting homelessness. Subst Use Misuse. 2003;38(3-6):577–99. Accessed May 26, 2019. http://www.ncbi.nlm.nih.gov/pubmed/12747398 doi:10.1081/ja-120017386.
   PubMed Web of Science ®Google Scholar
• Langendam MW, Van Brussel HA, Coutinho RA, Van Ameijden EJC. The Impact of Harm-Reduction-Based Methadone Treatment on Mortality Among Heroin Users. Vol 91.; 2001. Accessed May 26, 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1446673/pdf/11344886.pdf.
   Google Scholar
• Palepu A, Strathdee SA, Hogg RS, Anis AH, Rae S, Cornelisse PG, Patrick DM, O’Shaughnessy MV, Schechter MT. The social determinants of emergency department and hospital use by injection drug users in Canada. J Urban Health. 1999;76(4):409–18. doi:10.1007/BF02351499.
   PubMed Web of Science ®Google Scholar
• Handford C. Buprenorphine/Naloxone for Opioid Dependence: Clinical Practice Guideline. Accessed November 7, 2018. http://cpsa.ca/wp-content/uploads/2015/07/buprenorphine_naloxone_CAMH2012.pdf.
   Google Scholar
• Rae BE, Rees S. The perceptions of homeless people regarding their healthcare needs and experiences of receiving health care. J Adv Nurs. 2015;71(9):2096–107. doi:10.1111/jan.12675.
   PubMed Web of Science ®Google Scholar
• Phelan J, Link BG, Moore RE, Stueve A. The stigma of homelessness: the impact of the label “homeless” on attitudes toward poor persons. Soc Psychol Q. 1997;60(4):323–37. doi:10.2307/2787093.
   Web of Science ®Google Scholar
• Martins DC. Experiences of homeless people in the health care delivery system: a descriptive phenomenological study. Public Health Nurs. 2008;25(5):420–30. doi:10.1111/j.1525-1446.2008.00726.x.
   PubMed Web of Science ®Google Scholar
• Evans JL, Hahn JA, Lum PJ, Stein ES, Page K. Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study). Drug Alcohol Depend. 2009;101(3):152–7. doi:10.1016/j.drugalcdep.2008.12.007.
   PubMed Web of Science ®Google Scholar
• Hakansson A, Schlyter F, Berglund M. Associations between polysubstance use and psychiatric problems in a criminal justice population in Sweden. Drug Alcohol Depend. 2011;118(1):5–11. doi:10.1016/j.drugalcdep.2011.02.014.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Wood E, Stoltz J, AnneLi K, Montaner J, Kerr T. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Public Health. 2008;122(1):70–8. doi:10.1016/j.puhe.2007.02.016.
   PubMed Web of Science ®Google Scholar
• Schneider KE, Park JN, Allen ST, Weir BW, Sherman SG. Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: a latent class analysis. Drug Alcohol Depend. 2019;201:71–7. doi:10.1016/j.drugalcdep.2019.03.026.
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39–45. doi:10.1016/J.DRUGALCDEP.2006.07.009.
   PubMed Web of Science ®Google Scholar
• Quinn DI, Wodak A, Day RO. Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users. Clin Pharmacokinet. 1997;33(5):344–400. doi:10.2165/00003088-199733050-00003.
   PubMed Web of Science ®Google Scholar
• McCrady BS, Epstein EE. Addictions: a comprehensive guidebook. Published online 1999. http://ubc.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV07C8IwED60grhpVWyt4h-olKSv jCIWFzf3kscFXFz8_2DSpqil4JjAhVwI98z3BYCSYxL3 bIIxlFTzJOWoS5kwpSVmiuaWfUwzIbK_T3-X6UL vB7gwx8XVpCU3HtCi8z69ubShseWpoy6qT2SyAEU fA043LH-i99S_VHDyLOVjACJ8-TG-u372E2UmpR4M8eK0.
   Google Scholar
• Bruce RD, Moody DE, Altice FL, Gourevitch MN, Friedland GH. A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Rev Clin Pharmacol. 2013;6(3):249–69. doi:10.1586/ecp.13.18.
   PubMed Web of Science ®Google Scholar
• Bogen DL, Perel JM, Helsel JC, Hanusa BH, Romkes M, Nukui T, Friedman CR, Wisner KL. WK. Pharmacologic evidence to support clinical decision making for peripartum methadone treatment. Psychopharmacology (Berl). 2013;225(2):441–51. doi:10.1007/s00213-012-2833-7.
   PubMed Web of Science ®Google Scholar